Tromsø, 3-5th of june 2026
Every eight years, we, the Norwegian Epidemiological Association (NOFE), have the pleasure of hosting the Nordic Conference of Epidemiology and Register-Based Health Research (NordicEpi). In 2026, it is our turn, and we are pleased to present the first joint NordicEpi & NorPEN Conference in Tromsø. This unique meeting will combine epidemiology and pharmacoepidemiology into a rich, collaborative scientific programme. The NordicEpi & NorPEN Conference will replace the annual national NOFE conference for 2026.
Nestled within Tromsø’s impressive arctic landscape and 24-hour sunlight, the conference will gather researchers, clinicians, and public health practitioners from across the Nordic countries and internationally. Over this three-day conference, attendees will share original research in pharmacoepidemiology and other epidemiologic fields, take part in methodological discussions, and form new collaborations.
On 2 June, three pre-conference workshops will be offered, open to all participants, providing an opportunity to deepen methodological knowledge in different fields before the main programme.
Visit the NordicEpi & NorPEN conference website for abstract submission, registration, and more details here
Confirmed Keynote Speakers for 2026
Camilla Stoltenberg, PhD, MD
Honorary Member of NOFE, the Chief Executive Officer (CEO) of NORCE and previous Director-General of the Norwegian Institute of Public Health (NIPH). Camilla Stoltenberg has played a central role in building Norway’s public health research infrastructure, including national registries, biobanks, and population cohorts, and especially in making the Norwegian Patient Registry personally identifiable and suitable for research. During the COVID‑19 pandemic, she was instrumental in shaping strategic projects and led the institute’s scientific communication.
Yu-Han Chu, MD, ScD
Assistant Professor, Department of Epidemiology, Brown University School of Public Health
Yu-Han Chu’s work focuses on the development and application of advanced causal inference methods, including target trial emulation and transportability, with particular emphasis on pregnancy and cardiovascular health.
Anton Pottegård, PhD
Professor of Pharmacoepidemiology, University of Southern Denmark
Anton Pottegård leads a large pharmacoepidemiology research group and specializes in applied pharmacoepidemiology, with a focus on research infrastructure, methodological best practices, and the transparent use of secondary health data.
Unnur Anna Valdimarsdóttir, PhD
Professor of Epidemiology and Dean, School of Health Sciences, University of Iceland
Unnur Anna Valdimarsdóttir’s research investigates the complex relationships between psychological trauma, mental disorders, and somatic diseases. Her work draws on Nordic registry, cohort, and biobank data and is supported by major international funding bodies.
Walter Ricciardi, MD, Hon PhD
Full Professor of Hygiene and Public Health at Università Cattolica del Sacro Cuore, Rome. European Parliament.
Walter Ricciardi currently serves as Chair of the European Commission’s Mission Board for Cancer and Chair of the Scientific Committee of the Human Technopole Foundation. He has held advisory roles for public health policy, including for the Italian Ministry of Health during the COVID-19 pandemic.